West Penn called off the merger Sept. 28, citing Highmark’s plan to restructure the health system through bankruptcy as a violation of the parties’ affiliation agreement. Highmark has maintained there was no breach of the agreement and has urged West Penn to continue with the $475 million merger, which is a centerpiece in the payor’s billion-dollar plan to develop a provider network.
In tonight’s meeting, executives from Highmark’s provider wing are expected to address the alleged breach and Highmark’s plans to repair it, according to the report. West Penn physicians are also reportedly opposed to the split and wish the health system would refrain from seeking new suitors. Highmark has taken legal action to do just that, as it recently filed an injunction to prevent West Penn from conducting new merger talks.
More Articles on Highmark and West Penn Allegheny:
Did Highmark’s Firing of CEO Dr. Ken Melani Prompt Problems With West Penn?
West Penn Faces Moody’s Downgrade After Nixing Highmark Merger
West Penn Allegheny Calls Off Highmark Merger
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
